Antibody products, monoclonal antibody (mAb) especially, have played a major role of the growing biologics drug market. For the diagnosis and treatment of various disease types, the development of monoclonal antibody therapeutics is almost the largest and most effective choice for oncological, immunological and anti-infectivetherapeutic areas. One reason of this interest is due to the exquisite specificity of mAbs. In general, a particular antigen can be specifically bound by a monoclonal antibody which has structurally identical antigen-binding regions recognize the same site of the antigen. This specificity can lead to highly selective interactions with interested targets involved in the pathology of disease, such as receptors, tissues and organs, and further minimizing the potential side effects.

While, the complex nature of antibody products presents a number of unique challenges during their development and manufacture of biopharmaceuticals. During the development and production of antibody based therapeutic drugs, it is essential to detect, characterize and quantify impurities as well as the important parameters about structural variants and modifications, affinity and immunogenicity to monitor the stability and safety of the final products. This physical truth has been emphasizing the need for innovative and efficient analytic tools and services. Fortunately, Bio.services is just the chosen one who is able to meet clients’ analytical needs by offering a wide range of services that have been specifically tailored to meet the quality analysis and high-throughput requirements of antibody therapeutic development projects. These services include antibody sequencing, affinity measurement, epitope binning, immunogenicity assessment, isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), dual-polarization interferometry (DPI) and more.

Our professional academic team have concentrated on the research and development of antibody realm for over decades and successfully contributed a range of services specifically tailored to antibody analytics. We are confident in applying our experience, industry and regulatory knowledge to design actual strategic packages pertinent to customers’ project.